439 related articles for article (PubMed ID: 20739402)
1. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption.
Kogawa M; Findlay DM; Anderson PH; Ormsby R; Vincent C; Morris HA; Atkins GJ
Endocrinology; 2010 Oct; 151(10):4613-25. PubMed ID: 20739402
[TBL] [Abstract][Full Text] [Related]
2. Evidence for altered osteoclastogenesis in splenocyte cultures from Cyp27b1 knockout mice.
Reinke DC; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():353-360. PubMed ID: 26639637
[TBL] [Abstract][Full Text] [Related]
3. The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts.
Kogawa M; Anderson PH; Findlay DM; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):277-80. PubMed ID: 20304055
[TBL] [Abstract][Full Text] [Related]
4. Modulation of osteoclastic migration by metabolism of 25OH-vitamin D3.
Kogawa M; Findlay DM; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2013 Jul; 136():59-61. PubMed ID: 22989483
[TBL] [Abstract][Full Text] [Related]
5. Analysis of vitamin D metabolism gene expression in human bone: evidence for autocrine control of bone remodelling.
Ormsby RT; Findlay DM; Kogawa M; Anderson PH; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2014 Oct; 144 Pt A():110-3. PubMed ID: 24120913
[TBL] [Abstract][Full Text] [Related]
6. Metabolism of vitamin D3 in human osteoblasts: evidence for autocrine and paracrine activities of 1 alpha,25-dihydroxyvitamin D3.
Atkins GJ; Anderson PH; Findlay DM; Welldon KJ; Vincent C; Zannettino AC; O'Loughlin PD; Morris HA
Bone; 2007 Jun; 40(6):1517-28. PubMed ID: 17395559
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the biological effects of exogenous and endogenous 1,25-dihydroxyvitamin D
Yang D; Anderson PH; Turner AG; Morris HA; Atkins GJ
J Steroid Biochem Mol Biol; 2016 Nov; 164():374-378. PubMed ID: 26949105
[TBL] [Abstract][Full Text] [Related]
8. Human trabecular bone-derived osteoblasts support human osteoclast formation in vitro in a defined, serum-free medium.
Atkins GJ; Kostakis P; Welldon KJ; Vincent C; Findlay DM; Zannettino AC
J Cell Physiol; 2005 Jun; 203(3):573-82. PubMed ID: 15573398
[TBL] [Abstract][Full Text] [Related]
9. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss.
Starczak Y; Reinke DC; Barratt KR; Ryan JW; Russell PK; Clarke MV; St-Arnaud R; Morris HA; Davey RA; Atkins GJ; Anderson PH
J Steroid Biochem Mol Biol; 2018 Mar; 177():77-82. PubMed ID: 29107736
[TBL] [Abstract][Full Text] [Related]
10. BSP and RANKL induce osteoclastogenesis and bone resorption synergistically.
Valverde P; Tu Q; Chen J
J Bone Miner Res; 2005 Sep; 20(9):1669-79. PubMed ID: 16059638
[TBL] [Abstract][Full Text] [Related]
11. (23S)-25-Dehydro-1{alpha}-hydroxyvitamin D3-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures from patients with Paget's disease.
Ishizuka S; Kurihara N; Reddy SV; Cornish J; Cundy T; Roodman GD
Endocrinology; 2005 Apr; 146(4):2023-30. PubMed ID: 15618361
[TBL] [Abstract][Full Text] [Related]
12. Effect of high phosphate concentration on osteoclast differentiation as well as bone-resorbing activity.
Kanatani M; Sugimoto T; Kano J; Kanzawa M; Chihara K
J Cell Physiol; 2003 Jul; 196(1):180-9. PubMed ID: 12767054
[TBL] [Abstract][Full Text] [Related]
13. Osteoprotegerin produced by osteoblasts is an important regulator in osteoclast development and function.
Udagawa N; Takahashi N; Yasuda H; Mizuno A; Itoh K; Ueno Y; Shinki T; Gillespie MT; Martin TJ; Higashio K; Suda T
Endocrinology; 2000 Sep; 141(9):3478-84. PubMed ID: 10965921
[TBL] [Abstract][Full Text] [Related]
14. Secreted frizzled-related protein-1 inhibits RANKL-dependent osteoclast formation.
Häusler KD; Horwood NJ; Chuman Y; Fisher JL; Ellis J; Martin TJ; Rubin JS; Gillespie MT
J Bone Miner Res; 2004 Nov; 19(11):1873-81. PubMed ID: 15476588
[TBL] [Abstract][Full Text] [Related]
15. Bone morphogenetic protein 2 enhances mouse osteoclast differentiation via increased levels of receptor activator of NF-κB ligand expression in osteoblasts.
Tachi K; Takami M; Zhao B; Mochizuki A; Yamada A; Miyamoto Y; Inoue T; Baba K; Kamijo R
Cell Tissue Res; 2010 Nov; 342(2):213-20. PubMed ID: 20941510
[TBL] [Abstract][Full Text] [Related]
16. Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice.
Reinke DC; Starczak Y; Kogawa M; Barratt KR; Morris HA; Anderson PH; Atkins GJ
J Steroid Biochem Mol Biol; 2018 Mar; 177():96-102. PubMed ID: 28765041
[TBL] [Abstract][Full Text] [Related]
17. Aging increases stromal/osteoblastic cell-induced osteoclastogenesis and alters the osteoclast precursor pool in the mouse.
Cao JJ; Wronski TJ; Iwaniec U; Phleger L; Kurimoto P; Boudignon B; Halloran BP
J Bone Miner Res; 2005 Sep; 20(9):1659-68. PubMed ID: 16059637
[TBL] [Abstract][Full Text] [Related]
18. Decoy receptor 3 (DcR3) induces osteoclast formation from monocyte/macrophage lineage precursor cells.
Yang CR; Wang JH; Hsieh SL; Wang SM; Hsu TL; Lin WW
Cell Death Differ; 2004 Jul; 11 Suppl 1():S97-107. PubMed ID: 15002040
[TBL] [Abstract][Full Text] [Related]
19. Saurolactam inhibits osteoclast differentiation and stimulates apoptosis of mature osteoclasts.
Kim MH; Ryu SY; Choi JS; Min YK; Kim SH
J Cell Physiol; 2009 Dec; 221(3):618-28. PubMed ID: 19653230
[TBL] [Abstract][Full Text] [Related]
20. New 19-nor-(20S)-1alpha,25-dihydroxyvitamin D3 analogs strongly stimulate osteoclast formation both in vivo and in vitro.
Sato M; Nakamichi Y; Nakamura M; Sato N; Ninomiya T; Muto A; Nakamura H; Ozawa H; Iwasaki Y; Kobayashi E; Shimizu M; DeLuca HF; Takahashi N; Udagawa N
Bone; 2007 Feb; 40(2):293-304. PubMed ID: 17070129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
